Chimera Investment Corporation (CIM) Earnings Call Transcript & Summary
February 15, 2023
Earnings Call Speaker Segments
Victor Falvo
executiveThanks, operator, and I appreciate all of you joining us for Chimera's call covering the fourth quarter and the full year of 2022. Before we get going, I want to go over the safe harbor statements. On this call, we'll be making forward-looking statements — that means predictions, projections, or other statements regarding events yet to come. Such statements rest on present expectations and assumptions, and they carry risks and uncertainties, all of which are described in the Risk Factors section of our latest annual and quarterly SEC filings. What actually happens, and what we actually report, could be materially different from these forward-looking statements. We urge you to look at the forward-looking statement disclaimer included in our earnings release, along with our quarterly and annual filings. We might also talk about non-GAAP financial measures today. For a reconciliation to the closest comparable GAAP measures, please see our SEC filings and earnings supplement. Also, what's said on this conference call could include time-sensitive information that holds true only as of today, the date of this earnings call. We don't undertake, and we specifically disclaim, any obligation to update or revise this information. At this point, I'll hand the conference over to Phillip Kardis, our CEO.
Phil Kardis
executiveHello everyone, and thanks for joining us for Chimera Investment Corporation's call covering both the fourth quarter and the entire 2022 fiscal year. Joining me today are our President and Chief Investment Officer, Choudhary Yarlagadda; Dan Thakkar, who serves alongside him as Co-Chief Investment Officer; our Chief Financial Officer, Subra Viswanathan; and Vic Falvo, who leads our Capital Markets team. After I wrap up my opening comments, Subra will take everyone through the numbers, and then we'll open things up for your questions. Before diving in, I'd like to share a bit of background about myself. Many of you are likely aware that between our internalization in 2015 and my move into the CEO role in December 2022, I served as the company's Chief Legal Officer and Corporate Secretary. Prior to joining as Chief Legal Officer, I spent time as a Partner at a large law firm, where one of my duties involved representing the company as outside counsel starting at its IPO and continuing until I stepped into this role. Something you may not be aware of is that I built broad experience well before reaching Partner status at a law firm — ranging from time spent on Capitol Hill and within the Executive branch, to a position as a Defense Analyst at a think tank, to work at a Fortune 50 company, to studying Economics as a tactful student. During my time as a Lawyer, my work revolved largely around putting together highly intricate financial deals. That deal-structuring experience has translated directly into what I do at this company, where I've had a hand in virtually every part of the business — sitting on both the investment and valuation committees, and assisting with the structuring of its transactions. Regulatory law isn't my background. Litigation isn't my background either. Nothing related to regulation or litigation at the company led to me becoming CEO; what got me here was my experience in transactions and strategy. One more thing worth mentioning: even though I bring that transactional and strategic background, the Chief Investment Officer role is not mine. We think going back to how things used to be, when the CEO and CIO positions were held by different people, is essential for us to succeed. With those roles split apart, we can keep our attention on the big picture over the long haul and still zero in on investment prospects and what's in our portfolio. Now, ahead of getting into that vision, I want to walk through what stood out in Q4 and across the full year. As everybody knows, we faced a tough 2022, particularly through the final 4 months. The inflation figure everyone watches topped out at about 9.1%, and by the time the year closed, the Fed had pushed its benchmark rate up from close to 0 to somewhere between 4.25% and 4.5%. Having studied economic history and being of an age where I actually experienced the late 1970s and 1980s, seeing the Fed get behind inflation and then scramble to catch up feels like a rerun. I recall buying our first house with my wife back in the late 1980s — a rate near 9.5% made us happy, since we'd needed an even pricier second mortgage just to be able to qualify for the first, yet we recognized what that property was worth as an asset. The familiarity wasn't the only thing; the effect on the company was what we'd anticipated. By year-end, our weighted average cost for recourse borrowing had climbed to about 6.6%, compared with roughly 2.3% twelve months before. Earnings available for distribution fell to $1.08 across the year and to $0.11 in Q4. The main drivers were a onetime severance charge tied to our former CEO, plus a $250 million fixed rate non-mark-to-market financing arrangement we put in place to strengthen liquidity while shielding us from rising interest rates affecting those assets. If you set aside those 2 items, EAD for the quarter would have come in at around $0.20. Through the back half of the year, we arranged a number of long-term non-mark-to-market facilities. We thought ahead, accepted what the Fed was saying about rates staying elevated for an extended period, and chose the sensible step of pushing some of our financing out into 2024 and past that, to a point where we had greater confidence the Fed would finish hiking and start lowering rates. Financing like that naturally costs more than short-term alternatives, yet it lowers the need for hedges that guard against margin calls, unlocking cash for other uses. Beyond that, we recognize that we are accumulating substantial equity within our securitizations, much like my wife and I did with our first home. Protecting the subordinate bonds we keep on our books by using this type of funding is in our shareholders' long-term interest, even when it requires us to pay more. Even so, there were many positive things happening in the fourth quarter. In addition to lengthening the terms of our financings, we moved about $463 million in prime jumbo loans into a long-term financing facility that works as effectively fixed rate and non-mark-to-market. We consider the returns from this investment to be accretive to our shareholders. Through our sponsorship of the CIM 2022-NR1 securitization, we reduced our mortgage loan mark-to-market exposure by roughly $100 million. Beyond that, book value per common share rose to $7.49 by the close of the fourth quarter. January carried the momentum forward: we tapped the securitization market, closed 4 of our securitizations, and issued 2 new ones, which lowered recourse borrowing by roughly $139 million and freed up about $90 million in equity. We additionally committed to buying approximately $700 million of reperforming loans, which we plan to settle into securitizations, and we view the returns from these investments as accretive to our shareholders. We also purchased more business purpose loans, finishing January with $365 million in cash. Lastly, thus far in February, we have committed to acquiring about $200 million of non-QM loans, which we again expect to be accretive to our shareholders. So what comes next? Our mission is straightforward: generate appealing risk-adjusted returns for our shareholders by operating as the best-in-class credit mortgage REIT. Our assets, we believe, are quite strong. We've got roughly $900 million in legacy non-Agency RMBS still sitting on the balance sheet, and that piece keeps throwing off double-digit yields for the portfolio. At year-end, mortgage loans at fair value came to about $11.4 billion, and that figure includes RPLs held for investment. Those loans are the foundation stone of what we do. Reperforming loans make up the biggest slice of the loan portfolio. They're extremely seasoned. From the moment we acquired them, the numbers we track on credit results and prepayment activity have come in either stable or improved, which is why we've been able to complete securitizations and resecuritizations of them without trouble over the years. As time passes, those securitizations pay down their leverage, and that has traditionally created opportunities for Chimera to free up equity. Chimera then puts that equity to work by redeploying it into fresh assets, paying down debt, or returning it to shareholders as dividends. In our view, this ability to extract equity from our investments sets Chimera apart from others in the sector and could serve as a significant funding source for future deployment. We continue to encounter interesting, accretive opportunities in RPLs, non-QM, BPLs and jumbo prime mortgages. Our focus over the last several years has centered entirely on RPLs, and we anticipate continuing to broaden the range of loans we buy. Beyond that, we have traditionally maintained sizable holdings of Agency RMBS and Agency CMBS. Our plan is to gradually restore those holdings, both for the yield they provide and for the liquidity that backs our credit portfolio.
Phil Kardis
executiveBecause REITs are unable to hold onto earnings, we frequently discover that we can issue equity at times when yields on credit assets aren't appealing. In the same way, when credit opportunities look appealing, as they do right now, raising capital may prove difficult; in our view, these Agency portfolios let us even out such periods. We're able to expand our Agency portfolios and deploy the added liquidity toward buying credit assets when they're appealing, or toward backing our funding of credit assets when markets are more strained. Though these portfolios will underpin our core business, we'll run them with suitable leverage and hedging so they produce current income and preserve book value, which supports both our dividend and our investment in credit assets. This strategy isn't new to us. We employed it effectively from internalization through the pandemic. Over that stretch, our Agency RMBS and CMBS portfolio combined swung between a low of roughly $4 billion and a high of a bit above $12 billion, based on what opportunities existed for investing in credit assets. Now, we do believe 2023 brings difficulties. January showed us plenty of encouraging signs, and we think positive trends persist. Even so, we also notice a few dark clouds. Bringing inflation down to 2%, should that be achievable, will require time. A recent Wall Street Journal article notes that service industries — health care, hospitality and so on — make up 36% of all private sector payrolls. In contrast, the tech-heavy information sector represents just 2%. Over the last 6 months, those service industries have generated roughly 63% of all private sector job gains, and labor demand within them stays robust. So we take the Fed at its word when it says rates will rise higher for longer. And we think we've positioned ourselves to cope with that result. We're also attentive to the second cloud: liquidity swings stemming from debt ceiling antics. With regard to this cloud, we're watching our financing and roll dates closely. Last, there's the known unknown of geopolitical upheaval — Russia, China, Iran and North Korea especially. How such upheaval will play out is unknown; however, given our long-term financing, hedging and cash positions, we think we're positioned to cope with a range of stress scenarios. Even with these clouds, I feel optimistic about what lies ahead. We have a great team, outstanding assets and a clear vision. I'd now like to hand things to Subra for a more detailed overview of our financial results.
Subramaniam Viswanathan
executiveThanks, Phil. I'll go over Chimera's results for Q4 and the entirety of 2022. At the close of the fourth quarter, GAAP book value stood at $7.49 per share, and our economic return on that book value came to 3.8%, calculated from the quarter-over-quarter change in book value plus the dividend per common share paid in Q4. For the whole year, economic return was negative 27.3%. GAAP net income in Q4 reached $79 million, equal to $0.34 per share. GAAP net loss across the full year totaled $587 million, or $2.51 per share. Turning to earnings available for distribution, net income for the fourth quarter was roughly $0.11 per diluted common share, and $0.16 per diluted common share once you set aside a onetime severance expense tied to our former CEO's separation. For the full year, earnings available for distribution came to $256 million, or $1.08 per share. Economic net interest income was $77 million in Q4 and $436 million across the full year. During the fourth quarter, average interest-earning assets yielded 5.5%. Our average cost of funds came in at 3.9%, producing a net interest spread of 1.6%. Total leverage in Q4 was 4x:1, and recourse leverage finished the quarter at 1.3:1. For the year, economic net interest return on equity was 14.7%, while GAAP return on average equity was negative 16.7%. Finally, our 2022 expenses, once servicing fees and transaction expenses are excluded, totaled $72 million, a modest increase versus the prior year. That wraps up our remarks. We're ready now to take your questions.
Mike Smyth
analystMichael Smyth here, filling in for Bose. You said you plan to rebuild the Agency RMBS and CMBS portfolios. I'm curious — as a share of capital, how large do you see that becoming? And what would the timeline look like to reach that point?
Phil Kardis
executivePhil here. Appreciate the question. No set timeline exists. We'll evaluate what the market offers for each. Based on relative value, we'll begin shifting into those assets. On sizing, I believe we'll be considering a floor — what we view as the smallest portfolio size that works effectively or efficiently in this area — yet the real size will hinge on how large our credit portfolio is and where we foresee things heading regarding potential investments. So we won't spend money just to hit 10% or 25%; instead, we'll examine it more holistically at a given time.
Mike Smyth
analystGreat. Then, regarding those loan purchases, I wanted to ask: can you buy the loans and, more or less, securitize them at nearly the same moment, so you're able to steer clear of the danger that comes with keeping those loans on the balance sheet and financing them through repo?
Phil Kardis
executiveExactly right. That's what we're aiming to do; it's possible that we — given how the timing works out — wind up holding them in warehouse for about a week, but when we buy these, the goal is for them to settle straight into securitization.
Mike Smyth
analystGreat. Then perhaps just one additional item. You mentioned those purchases would be accretive. Could you sort of take us through the anticipated ROE? And sort of what does this presume regarding structural leverage? And does it presume any repo leverage on the pieces being retained?
Phil Kardis
executiveYes. We believe it's — we're discussing a figure around the mid-teens for returns, and leverage on the retained pieces would be part of that.
Trevor Cranston
analystYou mentioned that you plan to expand the kinds of loans you'll purchase going forward, moving past the usual RPLs. Looking at the newer categories such as non-QM and BPL, could you share where you believe the greater chance lies, in terms of the volume of loans that can be sourced and the yields you expect from those investments?
Phil Kardis
executiveTo start, BPLs are something we're quite fond of. In our view, the yields are strong, and we appreciate the brief duration. Sometimes buying them at scale proves difficult, yet we're constantly on the lookout for chances there. So — however, when it comes to non-QM, that's an area we historically haven't participated in. Still, regarding certain types of investor loans and similar products within that space, we're currently seeing appeal. Deals are presenting themselves to us, and we're — we believe our purchases there will increase moving ahead.
Trevor Cranston
analystAll right, understood. Now I'd like to ask about the dividend. Looking at the fourth quarter, specifically the earnings for that period, once you strip out the one-time items, it appears the figure still moved lower because the cost of funds went up. Could you explain the way you're approaching the dividend in light of that pattern, and perhaps also mention whatever additional things the Board weighs, apart from the EAD metric alone, when the dividend gets determined?
Phil Kardis
executiveAbsolutely. Appreciate it. Among the metrics we use is EAD. It isn't the sole one; and while it can serve as a solid gauge for particular elements at certain moments, it isn't entirely reliable in every case. So the Board, I'd say, examines many different considerations, among them the overall cash being produced by the portfolio, and a portion of that simply doesn't show up in the EAD metric; we also keep in mind, as I noted earlier, that equity we hold in our securitizations exists; therefore, based on timing and what our requirements happen to be, we might draw on it occasionally; so all of these things are part of the picture whenever we consider — or whenever the Board considers — the dividend. And so they felt — with the portfolio in its current position, they felt at ease approving the first quarter dividend of $0.23 even though EAD sits where it does right now.
Lee Cooperman
analystI just want to offer one observation. You mentioned that History is something you study.
Phil Kardis
executiveThat's right.
Lee Cooperman
analystAnyone who's studied History would've seen that rates were climbing. So why did you wait until this point to hedge?
Phil Kardis
executiveIn hindsight, yes, that's a step the company ought to have taken. What I'd say is — at this moment, Lee, our focus is really on what lies ahead. Leadership has changed; we've got a clear sense of direction. When it comes to hedging against our longer-term financing, we now have both a structure and a strategy in place. That's the situation we're in. I too have studied History. Still, honestly, that belongs to our past, and our attention is on correcting it and pushing ahead.
Lee Cooperman
analystOkay. So this was something someone brought up earlier, and you gave an indirect answer, and the approach you intend to take in operating the business was a sensible ROE for us to produce against that $7.49 of book value.
Phil Kardis
executiveThat's essentially our — it isn't truly our dividend return, somewhere in the 10% to 12% range.
Subramaniam Viswanathan
executiveHistorically.
Phil Kardis
executiveHistorically.
Lee Cooperman
analystHonestly, a 10% return on equity wouldn't be enough. With a 10% return on equity, the dividend would come to $0.75. That would mean a reduction.
Subramaniam Viswanathan
executiveHistorically, that's what it was.
Phil Kardis
executiveGo ahead there.
Subramaniam Viswanathan
executiveLee, Subra here. Going back, the yield on our shares has typically sat in the 10% to 12% range, and that is the level at which we anticipate our dividend — where our investments are presently yielding, and that is the level at which we view dividends as the return on capital one should expect from the stock.
Lee Cooperman
analystSo then, what exactly is your point? The distributable income is set by return on equity, and that in turn sets the dividend. In other words, are you stating that return on equity ought to land between 10% and 12%?
Subramaniam Viswanathan
executiveYes.
Lee Cooperman
analystAll right. So what you're saying suggests the payout is somewhat uncertain at this point — should we tell our shareholders there's a strong possibility the dividend gets cut within the coming 12 months? Or is your view that it probably stays as is?
Phil Kardis
executiveNo. At this moment, we're comfortable with where things stand, given how our portfolio generates cash and the fresh investments we're putting money into. Predicting what lies ahead is difficult, especially with market conditions and those possible dark clouds we mentioned. Still, as of now, that $0.23 dividend is something we feel good about.
Lee Cooperman
analystGiven your balance sheet, I'm assuming you've got ample capital to operate the company. More capital isn't necessary.
Phil Kardis
executiveThat's right, we have ample capital to operate the company in its present form. However, as we said regarding expanding the other portfolios and investment opportunities, to be clear, we won't hesitate to raise money if it's raised at a rate that works for us to put back into the assets; so if we see a positive return on that capital, we won't hesitate to raise additional pots.
Lee Cooperman
analystAll right. On the equity side, at the levels we're seeing now, would you look at raising equity?
Phil Kardis
executiveYes, I'd look at it — it would depend on what investment opportunities are available when we're able to get to market.
Lee Cooperman
analystSo you'd be selling shares for less than what the books say they're worth?
Phil Kardis
executiveNo, that's not what I said. What I said was that capital isn't something we'll put at risk...
Lee Cooperman
analystThat's what I'm doing — putting the question to you. Let me lay out where I stand. In the BDC, MLP, and REIT arenas, Wall Street has manufactured plenty of businesses. Those businesses only function if shares trade above net asset value. Here's why: you issue equity, you acquire assets, you lift your payout. You issue equity, you acquire assets, you lift your payout. Once you're trading below NAV, everything falls apart. The only smart move is either to combine with another entity so you become more efficient and capture synergies, or to repurchase shares below their worth. Issuing equity beneath book value is completely illogical, and the right step would be to look at liquidating the company's affairs, return the capital to investors, and admit we got it wrong. Our shares have performed terribly.
Phil Kardis
executiveRight. We're not saying otherwise. Our plan would be to issue at book. The reason I hesitated briefly is that it hinges on the nature of the opportunity. Should we conclude it's hugely accretive, we'd at minimum weigh it, though that isn't where we start from.
Phil Kardis
executiveI want to express my appreciation to all of you for being on this earnings call — and honestly, it's my very first one. Having the chance to address you has been a real pleasure, and I'm eager to do this again going forward. Thanks so much.
Operator
operatorThank you for joining us, everyone; that wraps up what we had for today. At this point you're welcome to leave the call or sign out of the webcast, and we hope the remainder of your day goes well.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Chimera Investment Corporation transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Chimera Investment Corporation earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Chimera Investment Corporation or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.